Eugene Braunwald Selected Research

vorapaxar

1/2018	Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
1/2018	Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
3/2017	Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial.
1/2017	High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial.
10/2016	Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial.
7/2016	Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
4/2016	Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50).
3/2016	Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
1/2016	Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50.
11/2015	Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugene Braunwald Research Topics

Disease

276	Myocardial Infarction 03/2024 - 02/2002
174	Acute Coronary Syndrome 12/2022 - 02/2002
122	Stroke (Strokes) 01/2024 - 04/2004
115	Hemorrhage 01/2024 - 02/2002
113	Heart Failure 03/2024 - 03/2002
67	ST Elevation Myocardial Infarction 03/2024 - 03/2002
57	Atrial Fibrillation 01/2024 - 09/2010
45	Thrombosis (Thrombus) 03/2024 - 07/2002
34	Ischemia 10/2018 - 07/2003
33	Diabetes Mellitus 11/2021 - 10/2002
29	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 11/2002
29	Unstable Angina 02/2016 - 02/2002
23	Ischemic Stroke 02/2024 - 09/2009
22	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 04/2002
20	Coronary Disease (Coronary Heart Disease) 01/2018 - 03/2002
19	Infections 04/2018 - 04/2002
18	Hypertension (High Blood Pressure) 12/2023 - 02/2003
18	Type 2 Diabetes Mellitus (MODY) 10/2023 - 11/2011
17	Embolism (Embolus) 01/2023 - 10/2010
17	Atherosclerosis 03/2022 - 02/2003
17	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2021 - 04/2003
16	Peripheral Arterial Disease 02/2024 - 08/2004
16	Infarction (Infarctions) 10/2016 - 04/2002
15	Non-ST Elevated Myocardial Infarction 03/2024 - 02/2002
10	Body Weight (Weight, Body) 01/2024 - 03/2005
10	Inflammation (Inflammations) 01/2023 - 02/2003
10	Transient Ischemic Attack 11/2020 - 10/2011
9	Fibrosis (Cirrhosis) 01/2021 - 01/2012
9	Vascular Diseases (Vascular Disease) 09/2019 - 04/2003
9	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017 - 07/2002
8	Left Ventricular Dysfunction 03/2024 - 08/2004
7	Hemorrhagic Stroke 01/2021 - 08/2014
6	Hypotension (Low Blood Pressure) 03/2024 - 01/2019
6	Obesity 12/2023 - 10/2004
6	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2023 - 05/2017
6	Chronic Renal Insufficiency 01/2021 - 12/2004

Drug/Important Bio-Agent (IBA)

49	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
46	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 09/2010
43	edoxabanIBA 01/2023 - 10/2010
40	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 09/2002
39	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 04/2004
36	Clopidogrel (Plavix)FDA Link 01/2020 - 08/2004
33	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 02/2002
31	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 10/2010
28	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2005
27	Glycoproteins (Glycoprotein)IBA 01/2018 - 11/2002
27	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 03/2002
25	Atorvastatin (Lipitor)FDA Link 09/2019 - 04/2002
24	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 03/2015
23	TicagrelorIBA 12/2022 - 04/2014
23	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 02/2002
22	C-Reactive ProteinIBA 02/2024 - 04/2002
22	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 09/2004
22	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 04/2002
21	AnticoagulantsIBA 01/2024 - 03/2005
21	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
20	Ezetimibe (Zetia)FDA Link 10/2021 - 08/2014
20	Troponin IIBA 12/2018 - 04/2002
19	vorapaxarIBA 01/2018 - 09/2009
18	LipidsIBA 03/2022 - 04/2003
18	saxagliptin FDA Link 11/2021 - 11/2011
17	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 07/2007
16	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2024 - 11/2004
16	Neurofibromin 2 (Merlin)IBA 10/2015 - 06/2006
16	Ranolazine FDA Link 01/2015 - 06/2006
15	LDL CholesterolIBA 11/2020 - 03/2002
15	TroponinIBA 11/2020 - 09/2003
14	oxidized low density lipoproteinIBA 03/2022 - 03/2002
14	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2006
13	CreatinineIBA 10/2023 - 11/2003
12	omega-Chloroacetophenone (Mace)IBA 02/2024 - 06/2006
12	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2021 - 11/2008
12	RivaroxabanIBA 03/2019 - 05/2011
11	Enalapril FDA LinkGeneric 03/2024 - 01/2018
11	Vitamin K FDA Link 01/2024 - 10/2010
11	Natriuretic PeptidesIBA 12/2023 - 11/2004
11	Valsartan (Vals)FDA Link 01/2023 - 08/2010
11	Troponin T (Troponin T1)IBA 12/2022 - 09/2002
11	Factor Xa InhibitorsIBA 03/2019 - 10/2010
11	Eptifibatide (Integrilin)FDA Link 04/2014 - 04/2003
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2014 - 11/2004
10	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2014 - 04/2002
9	Neprilysin (Neutral Endopeptidase)IBA 11/2023 - 03/2015
9	DiureticsIBA 12/2018 - 03/2011
9	Thrombin Receptors (Thrombin Receptor)IBA 01/2018 - 12/2014
9	AntithrombinsIBA 08/2011 - 04/2002
8	Tenecteplase FDA Link 03/2024 - 04/2003
8	thienopyridineIBA 01/2016 - 11/2007
7	darapladibIBA 01/2021 - 10/2011
7	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 11/2004
6	Ramipril (Altace)FDA LinkGeneric 03/2024 - 11/2021
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 10/2002
6	Hemoglobins (Hemoglobin)IBA 10/2023 - 04/2005

Therapy/Procedure

171	Therapeutics 11/2023 - 03/2002
47	Percutaneous Coronary Intervention 01/2023 - 04/2002
25	Stents 12/2021 - 11/2007
21	Thrombolytic Therapy 01/2021 - 10/2002
21	Secondary Prevention 01/2020 - 03/2005
20	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2021 - 12/2002
18	Patient Readmission 01/2021 - 09/2002